Centene — Apr 28, 2026 release

The Company is increasing its 2026 premium and service revenues guidance range by $1.0 billion to a range of $171.0 billion to $175.0 billion driven by Medicaid. The Company is also increasing its investment and other income expectation by $50 million to $1.45 billion. The Company is updating its 2026 GAAP diluted EPS guidance floor to greater than $2.37 and its 2026 adjusted diluted EPS guidance floor to greater than $3.40. The Company's annual guidance for 2026 is as follows and will be discussed further on our conference call: Full Year 2026 GAAP diluted EPS > $2.37 Adjusted diluted EPS (1) > $3.40 (1) A full reconciliation of adjusted diluted EPS is shown in the Non-GAAP Financial Presentation section of this release. Full Year 2026   Low High  Total revenues (in billions) $ 187.5  $ 191.5  Premium and service revenues (in billions) $ 171.0  $ 175.0  HBR 90.9  % 91.7  % SG&A expense ratio 7.0  % 7.6  % Adjusted SG&A expense ratio (2) 7.0  % 7.6  % Effective tax rate 27.0  % 28.0  % Adjusted effective tax rate (3) 26.0  % 27.0  % Diluted shares outstanding (in millions) 495.6  498.6  (2) Adjusted SG&A expense ratio excludes severance costs of approximately $20 million to $24 million and acquisition and divestiture related expenses of approximately $575 thousand. (3) Adjusted effective tax rate excludes income tax effects of adjustments of approximately $165 million to $169 million. 4 Conference Call As previously announced, the Company will host a conference call Tuesday, April 28, 2026, at 8:30 a.m. ET to review the financial